Compass Pathways | Biotechnology Company
Compass is a biotechnology company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.
Why COMPASS Pathways (CMPS) Is Up 15.4% After Psilocybin Phase …
11 hours ago · Earlier this month, COMPASS Pathways welcomed a White House Executive Order aimed at accelerating treatments for serious mental illness, as it reported two positive phase 3 trials …
Compass Pathways Cheers Trump Order To Accelerate Access To
Compass Pathways PLC CMPS said a White House executive order aimed at accelerating mental health treatment research could help speed access to its experimental psilocybin therapy, which the ...
Compass Pathways Commends White House Executive Order to …
3 days ago · Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House ...
Compass Pathways Phase 3 Results Raise Hopes For FDA Approval
Feb 20, 2026 · Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to …
Compass Pathways Rises on White House Support and Strong Phase 3...
1 day ago · Compass Pathways' stock climbs following a White House executive order supporting research and access to psychedelic treatments. With positive results from two phase 3 trials in …
Why COMPASS Pathways (CMPS) Is Up 15.4% After Positive Phase 3 ...
1 day ago · Earlier this month, COMPASS Pathways reported that its COMP360 synthetic psilocybin achieved highly statistically significant and clinically meaningful results in two phase 3 trials for …
Compass Pathways - Wikipedia
Compass Pathways is the largest company in the psychedelic medicine industry [5] and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. [1]
Psychedelic Drugs: The Executive Order Sending Compass Pathways …
10 hours ago · Compass Pathways stock surged Monday after President Donald Trump signed an executive order tied to psychedelic drugs.
Compass Pathways - Compass Pathways Successfully Achieves …
Feb 17, 2026 · “TRD patients have extremely limited treatment options, and the unmet need remains profound. The promising clinical profile of COMP360 reinforces our belief in its potential to set a new …